Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 16S ribosomal RNA (rRNA) aminoacyl-tRNA site (A-site) is a critical functional region within the 30S small ribosomal subunit of bacteria [10]. It serves as the decoding center where the anticodon of an incoming aminoacyl-tRNA is matched with the mRNA codon to ensure translational fidelity [6, 9]. This site is the primary target for several classes of antibiotics, most notably aminoglycosides, which bind specifically to the highly conserved internal loop of helix 44 in the 16S rRNA [4, 7]. By binding here, these drugs induce a conformational change that mimics the state of a correct codon-anticodon match, leading to the incorporation of incorrect amino acids and the synthesis of non-functional or toxic proteins [3, 4]. Because the bacterial A-site differs structurally from the eukaryotic mitochondrial and cytosolic counterparts, it provides a basis for selective toxicity [1, 2]. However, similarities to mitochondrial 12S rRNA can lead to adverse effects like ototoxicity in susceptible individuals [1, 6]. Beyond translation, the A-site is also involved in the assembly of the 30S subunit, making it a multifaceted target for antimicrobial therapy [3, 5].
Aminoglycosides bind to the A-site of the 16S rRNA, specifically at the internal loop of helix 44, inducing a conformational change (flipping out of A1492 and A1493) that mimics correct codon-anticodon recognition [4, 6]. This leads to the incorporation of incorrect amino acids (mistranslation) and can also inhibit the translocation of the ribosome along the mRNA [1, 3]. Tetracyclines bind to the A-site to physically block the entry of aminoacyl-tRNA, thereby inhibiting the elongation phase of protein synthesis [6, 8].
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 16S ribosomal RNA (16S rRNA) aminoacyl-tRNA site (A-site) (16S rRNA A-site).